IceCure Medical Ltd. (ICCM): Cash & Equivalents
$8.90M
As of 2025-12-31
-27.8%
3-year compound annual growth
+20.5%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $8.90M | +17.6% | 2026-03-17, Balance as of period end |
| 2024-12-31 | $7.56M | -28.2% | 2026-03-17, Balance as of period end |
| 2023-12-31 | $10.53M | -55.5% | 2025-03-27, Balance as of period end |
| 2022-12-31 | $23.66M | -7.7% | 2024-04-03, Balance as of period end |
| 2021-12-31 | $25.62M | +631.6% | 2023-03-29, Balance as of period end |
| 2020-12-31 | $3.50M | n/a | 2022-08-22, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| IceCure Medical Ltd. (ICCM) | 2025-12-31 | $8.90M | +17.6% |
| Nuo Therapeutics, Inc. (AURX) | 2025-12-31 | $548.9K | +93.5% |
| OSR Health, Inc. (OSRH) | 2025-12-31 | $1.70M | +397.8% |
| Tenon Medical, Inc. (TNON) | 2025-12-31 | $3.76M | -42.5% |
| Intelligent Bio Solutions Inc. (INBS) | 2026-06-30 | $3.99M | +291.4% |
| QHSLab, Inc. (USAQ) | 2025-12-31 | $636.2K | +304.8% |
| Lucid Diagnostics Inc. (LUCD) | 2024-12-31 | $22.36M | +18.3% |
| Picard Medical, Inc. (PMI) | 2025-12-31 | $7.45M | n/m |
| Femasys Inc (FEMY) | 2025-12-31 | $9.27M | +168.5% |
Compare ICCM, AURX, OSRH, TNON side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗